Company attributes
Industry
B2X
CEO
Founder
Legal Name
Conagen, Inc.
Legal classification
Date Incorporated
June 19, 2014
Number of Employees (Ranges)
51 – 200
Phone Number
+178127115880
Full Address
15 Deangelo Dr Bedford, MA, 01730-2203 United States0
Investors
Founded Date
2010
Total Funding Amount (USD)
30,000,000
Latest Funding Round Date
April 2020
Competitors
Latest Funding Type
Patents Assigned (Count)
43
Country
Other attributes
Company Operating Status
Active
Conagen engineers live organisms to produce molecules. Conagen uses synthetic biology tools to design metabolic pathways, improve production organisms, and optimize production procedures. They focus on bio-production of high value ingredients for food, nutrition, pharmaceutical, and renewable material industries.
Conagen has successfully engineered terpenoid pathways, aromatic amino acid-related pathways, cell wall sugar monomers and polymers, proteins and peptides, and secondary metabolic pathways in bacteria, plants and fungi.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
